Acquisition Announced

Novartis acquisition of Pikavation

US$2bn consideration

Announced 20 Mar 2026

Advisers

Target
Pikavation
Acquirer
Novartis
Seller
Synnovation
Target based in
United States
Buyer based in
Switzerland
Seller based in
United States
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.